Developping new solutions for guided surgery


Fluoptics is an emerging company, founded to create and develop innovative imaging systems for real time guided surgery.
Management team

Odile Allard
Chairwoman and CEO....

Gained a strong experience during the last 25 years  in product marketing, B to B sales, partnership and management, in IT and software industry. She worked for international groups and leading companies.
Odile holds a MBA in business and management (IAE) and graduated from Conservatoire National des Arts et Metiers.

Philippe Rizo
Scientific Director (CSO)...

Former group leader in the field of optical imaging at CEA-LETI, has a 25 year experience in imaging and owns numerous technical publications and patents.
He initiated the CEA-LETI in vivo fluorescence imaging activity in 2001, with the development of fluorescence pre-clinical tomography and clinical intra-operative imaging systems (under industrialisation inside Fluoptics).
Philippe holds a PHD in Instrumentation (INPG).

Cécile Réal
Strategic Advisor...

President and founder of Bioprofile (1999-2007), innovative orthopedic implants, she rapidly developed the company and gained a strong experience in product development, business development and fund rising.  She developed an international distribution network and integrated Bioprofile within Nexa Orthopedics (Cal.) in 2005 before being acquired by Tornier in 2007.
Cécile is a biomechanics engineer (UTC Compiègne), and holds an International Business and Technology MBA (Finland).

Jean-Luc Coll
Scientific Advisor...

Holds a position of Director of research and is heading a laboratory at the Inserm Albert Bonniot Institute (Grenoble). 20 year experience of research in diagnosis and therapy specialized in cancer biomarkers.
Jean-Luc holds a science PHD (Lyon University).
Since 1994, he has specialised in the field of targeted delivery of large molecules for cancer biotherapy. Because non-invasive optical imaging methods in small animals are of great help in such applications, he has become deeply involved in these techniques, in order to document the tumor-targeting potential of the synthetic vector he was generating.

Denis Querleu
Medical Advisor...

Professor of oncology at the University of Toulouse Paul-Sabatier and head of the department of surgery at the Institut Claudius Regaud cancer center in Toulouse.
Denis Querleu also acts as a visiting professor at McGill University, Montreal, Canada. He has acted as the director of experimental research at the University of Lille, France.
His expertise field is gynaecologic cancer surgery. He pioneered in the 90's the laparoscopic approach for cancer surgery.
He is the coordinator of a multidisciplinary team including clinicians and researchers, in collaboration with units at Cornell University and the Institute of Cellular Biology in Singapore that focuses on ovarian cancers, from natural history of tumor dissemination to advances in intraoperative diagnosis.

Focused on cancer surgery improvement, our technology will give surgeons a radically new efficiency in tumor resection.



Fluoptics has been awarded the 2008 French Research and Industry Ministry Prize
.


logo

Partners



Fluoptics is a startup of CEA, and derives its technology from the CEA-LETI and Université Joseph Fourier.


minatec
Based in Grenoble, France,
it is part of the MINATEC research center.